Drug Search Results
More Filters [+]

NP-000888

Alternative Names: np-000888, np000888, np 000888
Latest Update: 2018-06-12
Latest Update Note: Clinical Trial Update

Product Description

for Plaque and Nail Psoriasis

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Topical

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Galderma
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for NP-000888

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Psoriasis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

RD.03.SPR.100535

P2

Completed

Psoriasis

2018-05-03

39%

Recent News Events

Date

Type

Title